Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
复制标题
阿仑单抗作为 B 细胞慢性淋巴细胞白血病的一线治疗：临床效果、感染并发症和里氏转化风险的长期随访
DOI：
10.1038/sj.leu.2404435
复制
发表时间：
2006
期刊：
影响因子：
11.4
通讯作者：
A. Österborg
中科院分区：
文献类型：
--
作者：
C. Karlsson;C. Karlsson;S. Norin;S. Norin;E. Kimby;E. Kimby;Birgitta Sander;Birgitta Sander;A. P. MacDonald;A. P. MacDonald;B. Nilsson;B. Nilsson;E. Johansson;E. Johansson;H. Mellstedt;H. Mellstedt;J. Lundin;J. Lundin;A. Österborg;A. Österborg
3 Graux C，Cools J，Melotte C，Quentmeier H，Ferrando A，Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36：1084-1089. 4 Weng AP，Ferrando AA，Lee W，Morris JP，Silverman LB，Sanchez-Irizarry C等. Activating mutations of NOTCH 1 in human T cell acute lymphoblastic leukemia. Science 2004; 306：269-271. 5张文忠，张文忠，张文忠. T细胞急性淋巴细胞白血病的细胞遗传学和分子遗传学：从胸腺细胞到淋巴母细胞。白血病2006; 20：1496-1510。
3 Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084–1089. 4 Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271. 5 Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006; 20: 1496–1510.